Effects of urotensin II in human arteries and veins of varying caliber

被引:81
作者
Hillier, C
Berry, C
Petrie, MC
O'Dwyer, PJ
Hamilton, C
Brown, A
McMurray, J
机构
[1] Univ Glasgow, Dept Med, Glasgow G12 8QQ, Lanark, Scotland
[2] Univ Glasgow, Dept Therapeut & Surg, Glasgow G12 8QQ, Lanark, Scotland
[3] Glasgow Caledonian Univ, Vasc Assessment Grp, Glasgow G4 0BA, Lanark, Scotland
关键词
peptides; vasoconstriction; arteries; veins;
D O I
10.1161/01.CIR.103.10.1378
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Urotensin II (UII) is the ligand for the GPR14 receptor and the most potent vasoconstrictor in the cynomolgus monkey. UII also contracts rat thoracic aorta. We studied the effect of human UII (hUII) in human blood vessels. Methods and Results-Small subcutaneous resistance arteries, internal mammary arteries, saphenous veins, and small subcutaneous veins were studied using standard techniques. Subcutaneous resistance arteries constricted in response to norepinephrine (maximum tension, 2.84 +/-0.38 mN/mm; the concentration required to produce 50% of the maximum response [EC50], 0.52 +/-0.07 mu mol/L) and endothelin-1 (maximum tension, 4.19 +/- 10.93 mN/mm; EC50, 1.6 +/-0.1 nmol/L). hUII did not contract these arteries, internal mammary arteries, or either type of vein, but it was a patent vasoconstrictor in rat thoracic aorta (maximum tension, 2.36 +/-0.2 mN/mm; EC50, 1.13 +/-0.36 nmol/L). Conclusions-hUII has no vasoconstrictor action in human arteries and veins of different sizes and vascular beds. Marked species differences in the actions of UII question its importance in human cardiovascular regulation.
引用
收藏
页码:1378 / 1381
页数:4
相关论文
共 15 条
[1]   Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J].
Ames, RS ;
Sarau, HM ;
Chambers, JK ;
Willette, RN ;
Alyar, NV ;
Romanic, AM ;
Louden, CS ;
Foley, JJ ;
Sauermelch, CF ;
Coatney, RW ;
Ao, ZH ;
Disa, J ;
Holmes, SD ;
Stadel, JM ;
Martin, JD ;
Liu, WS ;
Glover, GI ;
Wilson, S ;
McNulty, DE ;
Ellis, CE ;
Elshourbagy, NA ;
Shabon, U ;
Trill, JJ ;
Hay, DWP ;
Ohlstein, EH ;
Bergsma, DJ ;
Douglas, SA .
NATURE, 1999, 401 (6750) :282-286
[2]  
Bern H.A., 1985, Recent Progress in Hormone Research, V41, P533
[3]  
BOTTRILL, 2000, BR J PHARM, V130, P1865
[4]  
Conlon JM, 1996, J EXP ZOOL, V275, P226, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<226::AID-JEZ14>3.0.CO
[5]  
2-H
[6]   Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord [J].
Coulouarn, Y ;
Lihrmann, I ;
Jegou, S ;
Anouar, Y ;
Tostivint, H ;
Beauvillain, JC ;
Conlon, JM ;
Bern, HA ;
Vaudry, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15803-15808
[7]   Effects of nitric oxide and superoxide on relaxation in human artery and vein [J].
Hamilton, CA ;
Berg, G ;
Mcintyre, M ;
Mcphaden, AR ;
Reid, JL ;
Dominiczak, AF .
ATHEROSCLEROSIS, 1997, 133 (01) :77-86
[8]   Structural and functional assessment of small arteries in patients with chronic heart failure [J].
Hillier, C ;
Cowburn, PJ ;
Morton, JJ ;
Dargie, HJ ;
Cleland, JGF ;
McMurray, JJV ;
McGrath, JC .
CLINICAL SCIENCE, 1999, 97 (06) :671-679
[9]   FUNCTIONAL RECEPTORS FOR FISH NEUROPEPTIDE UROTENSIN-II IN MAJOR RAT ARTERIES [J].
ITOH, H ;
MCMASTER, D ;
LEDERIS, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 149 (1-2) :61-66
[10]   Cardiovascular actions of trout urotensin II in the conscious trout, Oncorhynchus mykiss [J].
LeMevel, JC ;
Olson, KR ;
Conklin, D ;
Waugh, D ;
Smith, DD ;
Vaudry, H ;
Conlon, JM .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1996, 271 (05) :R1335-R1343